Cornyn, Tillis Urge Blanche to Protect Life, Counter Dangerous Mail-Order Abortion Drugs
Cornyn, Tillis Urge Blanche to Protect Life, Counter Dangerous Mail-Order Abortion Drugs News Cornyn, Tillis Urge Blanche to Protect Life, Counter Dangerous Mail-Order Abortion Drugs July 15, 2026 WASHINGTON – U.S. Senators John Cornyn (R-TX) and Thom Tillis (R-NC) sent a letter to Acting U.S. Attorney General Todd Blanche ahead of his nomination hearing today in the Senate Judiciary Committee urging him to resolve the mail-order abortion lawsuit, Louisiana v. FDA, by agreeing to a court-ordered consent decree, which would end the unlawful Biden-era policy that removed in-person dispensing requirements for the dangerous chemical abortion drug, mifepristone, while FDA conducts its safety review. Excerpts from the letter are below, and the full text of letter can be viewed here . The lawmakers wrote: “We write to express our growing concern that the Department of Justice (DOJ) has not acted to stop the abortion industry’s unlawful and unsafe mail-order abortion drug practice.” “It is well within the power of the Department of Justice, under your leadership, to resolve the Louisiana v. FDA litigation, which is now back before the Fifth Circuit Court of Appeals. By agreeing to a consent decree under the supervision of the court, you can swiftly end this illegal, Biden-era policy and restore in-person dispensing requirements while we await FDA’s safety review,” they continued. “On June 24, we celebrated four years since the Supreme Court’s landmark ruling in Dobbs v. Jackson. But the sad truth is that the number of abortions has actually increased in that time. This is in large part because of the abortion industry’s efforts to expand the use of unsafe mail-order abortions. With every day that passes, more lives are at risk and are lost because of this harmful policy. DOJ can and must act,” they concluded.
403bdcb0-b0b8-4226-b659-7462d38eaf3dIssued within 24 hours
Other senators' releases published in the day before or after this one.